Renal Medullary Carcinoma — Trials

Renal Medullary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

11 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06444880	Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies	active not recruiting	Phase 2	15	M.D. Anderson Cancer CenterOTHER	1	Aug 6, 2026	clinicaltrials
NCT05347212	Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla	active not recruiting	Phase 2	30	M.D. Anderson Cancer CenterOTHER	1	Apr 15, 2026	clinicaltrials